title: [Inflammatory bowel diseases and pregnancy].
abstract: Inflammatory bowel disease (IBD) affects women during their reproductive years and 25% become pregnant after an initial diagnosis of IBD. Many choose voluntary infertility due to concerns on the influence of disease and medical therapy on pregnancy outcome. We suggest that a multidisciplinary approach may lessen the risks involved. Pre-pregnancy consultation, with conception during the IBD remission allows a pregnancy outcome similar to the general population. During pregnancy, the continuation of regular medications (except MTX and thalidomide) and nutritional support is crucial. IBD flares during pregnancy are best treated with steroidal or anti-TNF agents, until 30-32 weeks. Breastfeeding should be encouraged. Postpartum follow-up of patients by an integrated team ensures an optimal future perinatal outcome.
authors: Ariella Bar-Gil
authors: AB
authors: Shitrit
authors: Eran
authors: E
authors: Goldin
authors: Sorina
authors: S
authors: Grisaru-Granovsky
mesh_terms: D000328:Adult; D019468:Disease Management; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D010348:Patient Care Team / Q000458:organization & administration; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D012074:Remission Induction; D020379:Risk Adjustment / Q000379:methods; D012736:Sex Education / Q000379:methods*